Mechanisms of the antimetastatic activity of stable prostacyclin analogues: modulation of host immunocompetence. 1991

V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
Istituto di Semeiotica Medica, Universita' di Perugia, Italy.

UI MeSH Term Description Entries
D007121 Immunocompetence The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. Competence, Immunologic,Immunologic Competence,Immunological Competence,Competence, Immunological
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016285 Iloprost An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation. Ciloprost,Ventavis,ZK-36374,ZK 36374,ZK36374

Related Publications

V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
December 1994, Cancer metastasis reviews,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
December 1985, Circulation,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
June 1981, Science (New York, N.Y.),
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
May 2018, Molecular and clinical oncology,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
September 2007, Biochemical and biophysical research communications,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
February 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
August 1986, Arzneimittel-Forschung,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
January 1984, Acta physiologica Hungarica,
V Costantini, and A Giampietri, and M Allegrucci, and G Agnelli, and G G Nenci, and M C Fioretti
January 1989, Clinical & experimental metastasis,
Copied contents to your clipboard!